Introduction
Vogt-Koyanagi-Harada syndromeis a disorder of the central nervous system affecting the vision and hearing abilities of an individual in particular. The syndrome is initially characterized by severe headaches, intense pain in the eyes, vertigo (dizziness), and feeling of nausea.
Vogt-Koyanagi-Harada disease is an uncommon disorder. It is of unknown cause that involves multiple organ systems, including the eyes, auditory system (ears), skin, and the meninges (the protective covering of the brain and spinal cord). Rapid vision loss is the first symptom to occur. Severe pain in the head, spinning head (vertigo), vomiting and nausea, and feeling drowsy are some of the other neurological signs manifested. Hearing loss, alopecia (hair loss), and skin pigmentation may occur along with loss of color from the hair and eyelashes (poliosis).
Synonyms of Vogt-Koyanagi-Harada Syndrome:
-
Alopecia-poliosis-uveitis-vitiligo-deafness-cutaneous syndrome.
-
Harada syndrome.
-
Uveo Meningitis disease.
-
VKH syndrome.
What Is the Etiology of Vogt-Koyanagi-Harada Syndrome?
The exact cause of the disease is not known fully but it is postulated that patients often develop a T-cell-mediated autoimmune response against the melanocytes (melanin-producing cells) after being exposed to a viral infection. It is believed to be an autoimmune disorder that occurs when the natural defenses of the body's immune system such as antibodies, and lymphocytes, begin to act against the healthy tissues in the body.
Viruses like cytomegalovirus (CMV) and Epstein-Barr virus have been found to play an important part in the pathogenesis of the disease. Vogt- Koyanagi-Harada disease is thought to occur because of the lack of tolerance in the melanocytes. This leads to a granulomatous inflammation of the non-necrotizing type in the eyes, ears, skin, and hair.
Certain genetic markers found on chromosome 6 are also believed to pose risk for the development of Vogt-Koyanagi-Harada syndrome. Some scientists consider a genetic predisposition for the disease since it has developed in a set of twins.
What Is the Epidemiology of Vogt-Koyanagi-Harada Syndrome?
It is a very uncommon disorder affecting both men and women equally. It is found that the disease is more commonly presented in patients suffering from uveitis. In fact, it is the most common causative factor of uveitis in Indians followed by Thailand. The disease is more prevalent in Asian and American people than in European people. The disease can occur at any age though it most commonly occurs at the age of 30 to 40 years.
What Are the Signs and Symptoms of Vogt-Koyanagi-Harada Syndrome?
The disease is characterized by severe headache along with severe pain in the eyes, followed by vertigo (spinning head), and vomiting in the prodromal phase. Inflammation of the eyes (uveitis) along with progressive loss of vision is the other symptoms that follow the prodromal symptoms in the acute uveitis phase in a few weeks. Either one or both eyes are affected by the disease. Loss of hearing sensation and retinal detachment also occurs in another few weeks.
The chronic phase follows the acute phase in a few weeks. The chronic stage is characterized by visible eye and skin changes. Loss of color in the choroid layer of the eye along with the presence of yellowish nodules developed in some parts of the retina. Changes in the skin are accompanied by the appearance of a condition known as vitiligo (loss of skin pigmentation) that leads to the formation of white patches on the skin. The chronic stage usually lasts from several weeks to several months to several years.
The chronic phase might reoccur in the recurrent phase characterized by panuveitis (all the layers of the eye are inflamed).
How Is the Diagnosis of Vogt-Koyanagi-Harada Syndrome Made?
There is a diagnostic criterion for the disease that includes inflammation of the eyes bilaterally, with no other evidence present of another eye disorder causing this inflammation, and the patient has no history of injury to the eyes or eye surgery. Three categories of the disease have been established for each diagnosis:
-
Complete Vogt-Koyanagi-Harada Syndrome: Bilateral panuveitis involving retinal detachments usually develop in patients. The complete form of this disorder includes clinical signs such as tinnitus, neck rigidity, skin changes like white patches on the arms, sudden alopecia, and even loss of color in the hairs, and eyelashes.
-
Incomplete Vogt-Koyanagi-Harada Syndrome: The changes in the eye are similar to those of the patients having a complete form of the disease but these patients will exhibit either neural or dermatological signs.
-
Probable Vogt-Koyanagi-Harada Syndrome: The eye changes are similar to the patients exhibiting a complete form of the disease but without showing any neurologic and dermatological signs.
The testing used by an eye specialist or neurologist in order to determine the presence of the disease includes a spinal tap (lumbar puncture), the injection of dye in the blood vessels to scan them (angiography), and ultrasonography.
What Is the Treatment of Vogt-Koyanagi-Harada Syndrome?
The gold standard treatment of Vogt-Koyanagi-Harada syndrome is the intake of initial high-dose systemic corticosteroids followed by immunosuppressive drug therapy. Another treatment modality is symptomatic and supportive to halt the process of inflammation.
The key to successful treatment is the aggressive use of systemic glucocorticoids. Intravitreal injections are also planned to treat eye inflammation.
What Are the Complications of Vogt-Koyanagi-Harada Syndrome?
Vogt-Koyanagi-Harada Syndrome is a systemic autoimmune inflammatory disease which if left untreated can lead to severe complications of the disorder including loss of hearing, dysacusis (hearing impairment), tinnitus (ringing bell in the ears), aural fullness (sensation of ear blockage), vitiligo (white patches appearing on the skin), vertigo (dizziness), and ophthalmic (eye) complications.
Conclusion
It is crucial to make the patients understand that Vogt-Koyanagi-Harada syndrome is an autoimmune systemic disorder that can recur and even relapse. If the disease is left untreated, the disease recurs repetitively and might lead to several complications, and patients often need immunosuppressive therapy for lifelong support. The healthcare professional should educate the patients on the various aspects and clinical manifestations of the syndrome to identify the recurrent form of the disease and seek medical help immediately. Early diagnosis along with both steroidal treatment and anti-steroidal immunosuppressants is a crucial requirement for the management of this syndrome.